~30,000 ft2 center will help biopharma shorten development timelines, reduce risk, and scale with confidence Supports multiple modalities including mAbs, pDNA/mRNA, recombinant proteins, and viral vectors Cytiva, a Danaher company and a leader in the life sciences industry, has inaugurated an expanded facility for Fast Trak process development (PD) and validation services in Bengaluru, India. The […]

 Revealed core proteomics instrument during US HUPO 2026 following successful field evaluation at the Buck Institute for Research on Aging Commercial launch expected to initiate in late 2026, marking a major milestone for next-generation proteomics Researchers invited to apply to the Early Access Program to use Iterative Mapping, Nautilus’ technology designed to measure billions of […]

Lebanon, NH – Bio X Cell announced the expansion of its bispecific antibody offerings, including a growing portfolio of ready-to-ship anti-mouse bispecific antibodies and custom bispecific antibody production services designed to support preclinical research. These ready-to-ship anti-mouse bispecific antibodies from Bio X Cell offer preclinical researchers the first-to-market RUO quality, off-the-shelf anti-mouse bispecific antibodies to […]

CAMBRIDGE, England & SAN DIEGO — biomodal, an omics-based life sciences technology and analytics company, today announced at the AGBT 2026 General Meeting that biomodal’s duet multiomic solutions are compatible with Element Biosciences AVITI24™ 5D multiomics and AVITI™ sequencing instruments. Validated at the University of Minnesota (UMN) Genomics Center, this integration delivers enhanced sensitivity for applications including […]

Portfolio innovations include the launch of the new CellScape XR spatial proteomics platform, the unique CosMx mouse whole transcriptome panel, the launch of the PaintScape platform for 3D genome visualization, extensive multiomics GeoMx capabilities, and AI-ready AtoMx analysis ORLANDO, Fla. — Bruker Corporation (Nasdaq: BRKR) announced today significant portfolio advancements from Bruker Spatial Biology to be […]

Vizgen will expand applications of MERSCOPE Ultra™ platform to include spatially-resolved molecular profiling of organoids; company has expansive pipeline and is progressing toward multiple breakthrough capabilities WALTHAM, Mass. — Vizgen, Inc., a leader in spatial multi-omics at single-cell resolution, today announced a series of innovations under development to help accelerate drug discovery, advance understanding of disease […]

CARLSBAD, Calif. – Thermo Fisher Scientific Introduces Sequential Protein/DNA/RNA Extraction Kit That Enables Genomic, Transcriptomic and Proteomic Analysis from a Single Sample to Support Cancer and Disease Research     Image:              Overview:                                    Thermo Fisher Scientific introduces the Thermo Scientific™ Sequential Protein/DNA/RNA […]

SAN DIEGO — Singular Genomics, a company delivering high-throughput spatial technologies to advance precision medicine, today announced the commercial launch and U.S. availability of G4X. The launch marks a major milestone in making large-scale spatial multiomics accessible for translational research, spatial pathology, and AI-driven insights. The G4X platform enables simultaneous analysis of 500-plex RNA, 18-plex protein and fH&E […]

Industry-first probes featuring computationally designed binding proteins provide unprecedented affinity, baseline stability, and data quality for antibody characterization and biologics research PALO ALTO, CA & Seattle, WA — Gator Bio, a pioneer in biolayer interferometry (BLI) technologies, today announced the commercial launch of its Gator HIS XT probes, the first biolayer interferometry probes to incorporate AI-designed binding […]

B-Body® platform complements Twist’s antibody discovery offering enabling rapid, efficient and precise expression and discovery of complex bispecific antibody therapeutics Platform to power high-throughput characterization of bispecific antibodies to fuel AI-enabled and traditional drug discovery SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that it has […]